Teva in $40bn push for Mylan as
pharma frenzy heats up -------------- Teva, the largest generic
drugmaker in the world, set the stage for the biggest pharma deal of the year by
launching an unsolicited $40bn offer to buy its nearest rival
Mylan. 梯瓦制药向迈兰发起巨额收购要约 -------------- 世界最大的仿制药制造商梯瓦(Teva)向其最大竞争对手迈兰(Mylan)发出400亿美元的主动收购要约,此举为今年医药行业最大一笔并购交易的上演搭好了舞台。
|